The case for sodium-hydrogen exchanger isoform-1 inhibition during cardiac resuscitation remains strong [8]

Critical Care Medicine

Volumn 34, Issue 5, 2006, Pages 1580-1582

  Gazmuri, Raúl J ^a   Ayoub, Iyad M ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CARIPORIDE; SODIUM PROTON EXCHANGE PROTEIN 1; ANTIARRHYTHMIC AGENT; GROWTH FACTOR ACTIVATABLE NA H EXCHANGER NHE 1; GROWTH FACTOR-ACTIVATABLE NA-H EXCHANGER NHE-1; GUANIDINE DERIVATIVE; SODIUM PROTON EXCHANGE PROTEIN; SULFONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; HEART ARREST; HEART FUNCTION; HEART INDEX; HEART VENTRICLE FIBRILLATION; HEMODYNAMIC PARAMETERS; LETTER; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; SWINE; TREATMENT OUTCOME; ANIMAL; DRUG ANTAGONISM; DRUG COMBINATION; METHODOLOGY; NOTE;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; CARDIOPULMONARY RESUSCITATION; DRUG THERAPY, COMBINATION; EPINEPHRINE; GUANIDINES; SODIUM-HYDROGEN ANTIPORTER; SULFONES; SWINE; VENTRICULAR FIBRILLATION;

EID: 33646574933     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000216687.86553.EC     Document Type: Letter

References (12)

1. Laudi S, Vu TZ, Steudel W: Cariporide in cardiac resuscitation: Does it really make a difference? Crit Care Med 2005; 33:2707-2708
2. Ayoub IM, Kolarova J, Kantola RL, et al: Cariporide minimizes adverse myocardial effects of epinephrine during resuscitation from ventricular fibrillation. Crit Care Med 2005; 33:2599-2605
3. Sagawa K, Suga H, Shoukas AA, et al: End-systolic pressure/volume ratio: A new index of ventricular contractility. Am J Cardiol 1977; 40:748-753
4. Gazmuri RJ, Ayoub IM, Hoffner E, et al: Successful ventricular defibrillation by the selective sodium-hydrogen exchanger isoform-1 inhibitor cariporide. Circulation 2001; 104:234-239
5. Ayoub IM, Kolarova JD, Yi Z, et al: Sodium-hydrogen exchange inhibition during ventricular fibrillation: Beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability. Circulation 2003; 107:1804-1809
6. Kolarova J, Yi Z, Ayoub IM, et al: Cariporide potentiates the effects of epinephrine and vasopressin by nonvascular mechanisms during closed-chest resuscitation. Chest 2005; 127:1327-1334
7. Kolarova JD, Ayoub IM, Gazmuri RJ: Cariporide enables hemodynamically more effective chest compression by leftward shift of its flow-depth relationship. Am J Physiol Heart Circ Physiol 2005; 288:H2904-H2911
8. Gazmuri RJ: Effects of repetitive electrical shocks on postresuscitation myocardial function. Crit Care Med 2000; 28:N228-N232
9. Idriss SF, Anstadt MP, Anstadt GL, et al: The effect of cardiac compression on defibrillation efficacy and the upper limit of vulnerability. J Cardiovasc Electrophysiol 1995; 6:368-378
10. Sanders RW, Ayoub IM, Kolarova JD, et al: Possible neuroprotective effects of zoniporide during resuscitation from cardiac arrest. Abstr. Crit Care Med 2004; 32:A57
11. Wirth KJ, Maier T, Busch AE: NHE1-inhibitor cariporide prevents the transient reperfusion-induced shortening of the monophasic action potential after coronary ischemia in pigs. Basic Res Cardiol 2001; 96:192-197
12. van Alem AP, Post J, Koster RW: VF recurrence: Characteristics and patient outcome in out-of-hospital cardiac arrest. Resuscitation 2003;59:181-188